الخميس 10 محرم 1448هـ
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
| عنوان الدراسة | داعم الدراسة | حالة الدراسة | دواء الدراسة | مرحلة الدراسة | رقم بروتوكول الدراسة | موقع الدراسة |
|---|---|---|---|---|---|---|
| Randomized, three-way, three-period, single oral dose, open-label, crossover, bioequivalence study to compare Torvacol tablets (20 mg atorvastatin) Produced by JPM / Jordan, versus Lipitor® tablets (20 mg atorvastatin) Produced by Pfizer / Irland in healthy subjects under fasting conditions. | SFDA | Ongoing | Torvacol | BE | 15-2017 | Saudi Ajal |
| Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Amlodar Capsules (10 mg amlodipine) Produced by Dar AlDawa / Jordan versus Amlor® Capsules (10 mg amlodipine) Produced by Pfizer / KSA, in healthy subjects under fasting condition. | SFDA | Ongoing | Amlodar | BE | 16-2017 | Saudi Ajal |
| Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Glibil tablets (5 mg glibenclamide) Produced by Hikma / Jordan versus Daonil® tablets (5 mg glibenclamide) Produced Sanofi-Aventis / Germany, in healthy subjects under fed condition. | SFDA | Ongoing | Glibil | BE | 17-2017 | Saudi Ajal |
| Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Diatab tablets (5 mg glibenclamide) Produced by SPIMACO / KSA versus Daonil® tablets (5 mg glibenclamide) Produced by Sanofi- Aventis / Germany, in healthy subjects under fed condition. | SFDA | Ongoing | Diatab | BE | 18-2017 | Saudi Ajal |
| "DIREGL07563 RATIONAL studyAn obseRvationAl registry To assess urInary albumin evOlution in Saudi hyperteNsive patients with the current treatment local ALgorithm " | SANOFI | Ongoing | APROVEL / Irbesartan | 4 | 3 | King Abdulaziz University Hospital (Jeddah) |
| Grazoprevir/Elbasvir For Treatment Of Hepatitis C Virus Genotype 4 Post Kidney Transplant | King Faisal Specialist Hospital & Research Center (MSD grant) | Ongoing | Zepatier | 4 | 2171009 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Solifenacin succinate film-coated tablets (10 mg solifenacin succinate) versus Vesicare® film-coated tablets (10 mg solifenacin succinate), in healthy subjects under fasting condition. | SPIMACO ADDWAEIH | Ongoing | solifenacin succinate | BE | Feb-17 | Saudi Ajal |
| A phase III randomized open-label multi-center study of ruxolitinib vs. best available therapy in patients with corticosteroid-refractory chronic graft versus host disease after allogenic stem cell transplantation | Novartis | Ongoing | Ruxolitinib (INC424) (Jakavi) | 3 | CINC424D2301 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| Phase II/III randomized multicentre study comparing neoadjuvant chemoradiotherapy followed by consolidation chemotherapy to neoadjuvant chemoradiotherapy alone in non-metastatic rectal cancer patients. | King Abdullah Medical City, Makkah | Ongoing | Capecitabine / oxaliplatin / FOLINIC Acid / FLUOROURACIL | 2 | IRB#17-329 version2 | King Abdullah Medical City (Makkah) |
| <p style="text-align: justify;">Long-term Safety and Efficacy Study of Ferriprox® for the Treatment of<br />Transfusional Iron Overload in Patients with Sickle Cell Disease<br />or Other Anemias</p> | ApoPharma | Ongoing | Deferiprone | 3b | LA38-EXT | Aseer Central Hospital |
تاريخ آخر تحديث: 08/05/2025 بتمام الساعة 03:17 مساء بتوقيت المملكة العربية السعودية
لم يتم تقديم أي تقييمات لهذه الصفحة بعد.
التعليقات والاقتراحات
لأي استفسارات أو ملاحظات حول الخدمات الحكومية، يرجى تعبئة المعلومات المطلوبة.